India's pharmaceutical industry has long been lauded for its capacity to provide affordable medications to a global market. However, beneath this facade of accessibility lies a concerning trend: the emergence of monopoly power within the sector. A handful of large corporations have amassed significant control over drug production and distribution,

India has emerged as a global powerhouse in the pharmaceutical sector, renowned for its affordable medications and robust manufacturing capabilities. However, beneath the surface of this success lies a complex landscape marked by concerns regarding monopolies and market dominance. A handful of large pharmaceutical companies have established signifi